ANVISA: Boosting U.S.-Brazil Health and Trade Cooperation

As Latin America’s largest economy, Brazil is a key player in the global healthcare market. At the heart of its regulatory framework is ANVISA, Brazil’s Health Regulatory Agency that has safeguarded the safety and efficacy of essential products, including pharmaceuticals, vaccines, and medical devices, for over two decades. Now, faced with a critical staffing crisis, ANVISA's ability to maintain its high standards, and its reputation as a global reference national regulatory authority ensuring the safety, efficacy, and quality of regulated health products that can support millions of patients . . .